Free Trial

Insider Buying: Dr. Martens plc (LON:DOCS) Insider Purchases 190 Shares of Stock

Dr. Martens plc (LON:DOCS - Get Free Report) insider Kenny Wilson acquired 190 shares of Dr. Martens stock in a transaction that occurred on Monday, May 13th. The shares were purchased at an average price of GBX 79 ($0.99) per share, for a total transaction of £150.10 ($188.52).

Kenny Wilson also recently made the following trade(s):

  • On Monday, March 11th, Kenny Wilson bought 163 shares of Dr. Martens stock. The stock was purchased at an average price of GBX 92 ($1.16) per share, for a total transaction of £149.96 ($188.34).

Dr. Martens Stock Up 2.2 %

DOCS stock traded up GBX 1.75 ($0.02) during trading on Tuesday, reaching GBX 79.60 ($1.00). 498,162 shares of the stock were exchanged, compared to its average volume of 1,752,710. The company has a current ratio of 2.44, a quick ratio of 1.13 and a debt-to-equity ratio of 143.48. Dr. Martens plc has a twelve month low of GBX 62 ($0.78) and a twelve month high of GBX 174.70 ($2.19). The firm's 50 day moving average is GBX 84.22 and its 200 day moving average is GBX 91.35. The firm has a market cap of £765.66 million, a P/E ratio of 796.00, a price-to-earnings-growth ratio of 0.04 and a beta of -0.03.

About Dr. Martens

(Get Free Report)

Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It offers originals, fusion, kids, and casual, as well as accessories. The company offers its products under the Dr. Martens brand name. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.

Featured Articles

Insider Buying and Selling by Quarter for Dr. Martens (LON:DOCS)

Should you invest $1,000 in Dr. Martens right now?

Before you consider Dr. Martens, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dr. Martens wasn't on the list.

While Dr. Martens currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Featured Articles and Offers

Search Headlines: